Patent 5915378 Issued on June 29, 1999. Estimated Expiration Date: October 27, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
128/200.22, Gas flow induced by expansion chamber device (e.g., piston/cylinder ram, squeeze bulb, etc.)128/200.14, LIQUID MEDICAMENT ATOMIZER OR SPRAYER128/204.23Means for sensing condition of user's body
Devices, packaging and methodology for efficiently and repeatably creating aerosolized bursts of an insulin containing formulation are disclosed. Devices are hand-held, self-contained units which are automatically actuated at the same release point in a patient's inspiratory flow cycle. The release point is automatically determined either mechanically or, more preferably calculated by a microprocessor which receives data from a sensor making it possible to determine inspiratory flow rate and inspiratory volume. The device is loaded with a cassette comprised of an outer housing which holds a package of individual disposable collapsible containers of an insulin containing formulation for systemic delivery. Actuation of the device forces insulin formulation through a porous membrane of the container which membrane has pores having a diameter in the range of about 0.25 to 3.0 microns, preferably 0.25 to 1.5 microns. The porous membrane is positioned in alignment with a surface of a channel through which a patient inhales air. The flow profile of air moving through the channel is such that the flow at the surface of the channel is less than the flow rate at the center of the channel. The membrane is designed so that it protrudes outward at all times or made flexible so that when an insulin formulation is forced against and through the membrane the flexible membrane protrudes outward beyond the flow boundary layer of the channel into faster moving air. Because the membrane protrudes into the faster moving air of the channel the particles of aerosol formed are less likely to collide allowing for the formation of a burst of fine aerosol mist with uniform particle size.
Other References
Barker et al., "Acidic Precursor Revealed in Human Eosinophil Granule Major Basic Protein cDNA," J. Exp. Med., 168:1493-1498 (1988)
Collins et al., "Continuous Growth and Differentiation of Human Myeloid Leukaemic Cells in Suspension Culture," Nature, 270:347-349 (1977)
Cullen et al., "Use of Eukaryotic Expression Technology in the Functional Analysis of Cloned Genes", Methods in Enzymology, 152:684-704 (1987)
Drazin et al., "Fungicidal Properties of a Chymotrypsin-Like Cationic Protein from Human Neutrophils: Absorption to Candida parapsilosis," Infect. Immun., 17:382-388 (1977)
Elsbach et al., "Separation and Purification of a Potent Bactericidal/Permeability-Increasing Protein and a Closely Associated Phospholipase A2 from Rabbit Polymorphonuclear Leukocytes," the Journal of Biological Chemistry, 254:11000-11009 (1979)
Elsbach et al., "Bactericidal/Permeability Increasing Protein (BPI) of Granulocytes: Structure and Function," Bacteria-Host Cell Interaction, 47-60 (1988)
Farley et al., "Antimicrobial Binding of a Radiolabeled Cationic Neutrophil Granule Protein," Infection and Immunology, 55:1536-1539 (1987)
Gabay et al., "Antibiotic Proteins of Human Polymorphonuclear Leukocytes," Proc. Natl. Acad. Sci., USA, 86:5610-5614 (1989)
Gabay et al., "Azurophil-derived Bactericidal Factor(s) from Human Neutrophils," Clinical Research, 34:676A (1986)
Gabay et al., "Subcellular Location and Properties of Bactericidal Factors from Human Neutrophils," J. Exp. Med., 164:1407-1421 (1986)
Ganz et al., "Defensins: Natural Peptide Antibiotics of Human Neutrophils," J. Clin. Invest., 76:1427-1435 (1985)
Gray et al., "Cloning of the cDNA of a Human Neutrophil Bactericidal Protein," the Journal of Biological Chemistry, 264:9505-9509 (1989)
Gray et al. "Cloning of the Gene of the Human Bactericidal/Permeability Increasing Protein and Identification of Structure-Function Relationships," Clinical Research, 36:620A (1988)
Gubler et al., "A Simple and Very Efficient Method for Generating cDNA Libraries," Gene, 25:263-269 (1983)
Heck et al., "Isolation, Characterization, and Amino-Terminal Amino Acid Sequence Analysis of Human Neutrophil Elastase from Normal Donors," Anal. Biochem., 149:153-162 (1985)
Heck et al., "Isoation, Characterization, and Amino-terminal Amino Acid Sequence Analysis of Human Neutrophil Cathepsin G from Normal Donors," Anal. Biochem., 158:217-227 (1986)
Heron, "System for Automated DNA Synthesis," American Biotechnology Laboratory, 2:52-54, 56, 58-59 (1984)
Hovde et al., "Physiological Effects of a Bactericidal Protein from Human Polymorphonuclear Leukocytes on Pseudomonas aeruginosa," Infect. Immun., 52:90-95 (1986)
Hovde et al., "Characterization of a Protein from Normal Human Polymorphonuclear Leukocytes with Bactericidal Activity against Pseudomonas aeruginosa," Infect. Immun., 54:142-148 (1986)
Hunkapiller et al., "High-Sensitivity Sequencing with a Gas-Phase Sequenator," Meth. Enzymol., 91:399-413 (1983)
Klein, Immunology: The Science of Self-Nonself Discrimination. John Wiley & Sons, NY. p. 101 (1982)
Larrick et al., "Complementary DNA Sequence of Rabbit Cap 18--A Unique Lipopolysaccharide Binding Protein," Biochem. Biophys. Research Communications 179:170-175 (1991)
Lehrer et al., "Correlation of Binding of Rabbit Granulocyte Peptides to Candida albicans with Candidacidal Activity", Infect. Immun., 49:207-211 (1985)
Maniatis et al., (eds.) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. pp. 188-199 (1982)
Muello et al., "The Role of Endotoxin in the Action of the Bactericidal/Permeability Increasing Neutrophil Protein on the Bacterial Envelope," Clinical Research, 31:371A (1983)
Nachman et al., "Studies on Isolated Membranes of Azurophil and Specific Granules from Rabbit Polymorphonuclear Leukocytes," J. Cell Biol., 54:133-140 (1972)
Odeberg et al., "Mechanisms for the Microbicidal Activity of Cationic Proteins of Human Granulocytes," Infect. Immun., 14:1269-1275 (1976)
Odeberg et al., "Antibacterial Activity of Cationic Proteins from Human Granulocytes," J. Clin. Invest., 56:1118-1124 (1975)
Okayama et al., "A cDNA Cloning Vector that Permits Expression of cDNA Inserts in Mammalian Cells," Molec. Cell Biol., 3:280-289 (1983)
Olsson et al., "Cationic Proteins of Human Granulocytes. II. Separation of the Cationic Proteins of the Granules of Leukemic Myeloid Cells," Blood, 44:235-246 (1974)
Ooi et al., "A 25-kDa NH2 -terminal Fragment Carries All the Antibacterial Activities of the Human Neutrophil 60-kDa Bactericidal/Permeability-Increasing Protein," J. Biol. Chem., 262:14891-14894 (1987)
Ooi et al., "Endotoxin-Neutralizing Properties of the 25 kD N-Terminal Fragment and a Newly Isolated 30kD C-Terminal Fragment of the 55-60 kD Bactericidal/Permeability-Increasing Protein of Human Neutrophils," J. Exp. Med., 174:649-655 (1991)
Pereira et al., "The Ontogeny of a 57-Kd Cationic Antimicrobial Protein of Human Polymorphonuclear Leukocytes: Localization to a Novel Granule Population," Blood, 76:825-834 (1990)
Rest et al., "Bactericidal Activity of Specific and Azurophil Granules from Human neutrophils: Studies with Outer-Membrane Mutants of Salmonella Typhimurium Lt-2," Infect. Immun., 19:131-137 (1978)
Salvesen et al., "Molecular Cloni ng of Human Cathespin G: Structural Similarity to Mast Cell and Cytotoxic T Lymphocyte Proteinases," Biochem., 26:2289-2293 (1987)
Sciarra et al., "In Vitro Release of Therapeutically Active Ingredients from Polymer Matrixes," J. Pharm. Sci., 65:1519-1522 (1976)
Selsted et al., "Primary Structures of three Human Neutrophil Defensins" J. Clin Invest., 76:1436-1439 (1985)
Selsted et al., "Primary Structures of Six Antimicrobial Peptides of Rabbit Peritoneal Neutrophils," J. Biol. Chem., 260:4579-4583 (1985)
Selsted et al., "Activity of Rabbit Leukocyte Peptides Against Candida albicans," Infect. Immun., 49:202-206 (1985)
Selsted et al., "Purification and Antibacterial Activity of Antimicrobial Peptides of Rabbit Granulocytes," Infect. Immun., 45:150-154 (1984)
Shafer et al., "Cationic Antimicrobial Proteins Isolated from Human Neutrophil Granulocytes in the Presence of Diisopropyl Fluorophosphate," Infect. Immun., 45:29-35 (1984)
Spitznagel et al., "A Monoclonal Antibody that Inhibits the Antimicrobial Action of a 57 KD Cationic Protein of Human Polymorphonuclear Leukocytes," J. Immunol., 139:1291-1296 (1987)
Starkey et al., "Neutral Proteinases of Human Spleen," Biochem. J., 155:255-263 (1976)
Suggs et al., "Use of Snythetic Oligonucleotides as Hybridization Probes: Isolation of Cloned cDNA Sequences for Human ଲ2 -microglobulin," Proc. Natl. Acad. Sci., USA 78:6613-6617 (1981)
Wallace et al., "The Use of Synthetic Oligonucleotides as Hybridization Probes. II. Hybridization of Oligonucleotides of Mixed Sequence to Rabbit ଲ-globin DNA," Nuc. Acids Res., 9:879-894 (1981)
Weiss et al., "Sensitivity of K1-Encapsulated Escherichia coli to Killing by the Bactericidal/Permeability-Increasing Protein of Rabbit and Human Neutrophils," Infect. Immun., 38:1149-1153 (1982)
Weiss et al., "The Role of Lipopolysaccharides in the Action of the Bactericidal/Permeability-Increasing Neutrophil Protein on the Bacterial Envelope", J. Immunol., 132:3109-3115 (1984)
Weiss et al., "Purification and Characterization of a Potent Bactericidal and Membrane Active Protein from the Granules of Human Polymorphonuclear Leukocytes," J. Biol. Chem., 253:2664-2672 (1978)
Weiss et al., "Structural and Immunological Dissection of Highly Conserved Bactericidal/Permeability-Increasing Proteins," Clinical Research, 34:537A (1986)
Weiss et al., "Cellular and Subcellular Localization of the Bactericidal/Permeability-Increasing Protein of Neutrophils," Blood, 69:652-659 (1987)
Weiss et al., "The Bactericidal/Permeability-Increasing Protein of Neutrophils Retains its Biological Activities after Cleavage by Neutrophil Proteases," Clinical Research, 33:567A (1985)
Weiss et al., "Environmental Modulation of Lipopolysaccharide Chain Length Alters the Sensitivity of Escherchia coli to the Neutrophil Bactericidal/Permeability-Increasing Protein," Infect. Immun., 51:594-599 (1986)
Weiss et al., "Partial Characterization and Purification of a Rabbit Granulocyte Factor that Increases Permeability of Escherichia coli," J. Clin. Invest., 55:33-42 (1975)
Weiss et al., "Role of Charge and Hydrophobic Interactions in the Action of the Bactericidal/Permeability-Increasing Protein of Neutrophils on Gram-negative Bacteria," J. Clin. Invest., 71:540-549 (1983)
Wilde et al., "Purification and Characterization of Human Neutrophil Peptide 4, a Novel Member of the Defensin Family," J. Biol. Chem., 264:11200-11203 (1989)
Young et al., "Efficient Isolation of Genes by Using Antibody Probes," Proc. Natl. Acad. Sci., USA 80:1194-1198 (1983)
Colthrope, P. et al., "The pharmacokinetics of Pulmonary-Delivered Insulin:A comparison of intratracheal and aerosol administration to the rabbit", 1992, Pharmaceutical Research, 9:764-768
Elliott, R.B. et al., "Parenteral absorption of insulin from the lung in diabetic children", 1987, Aust. Paediatr. J. 23:293-297
Kohler, D., "Aerosols for Systemic Treatment", 1990, Lung, Suppl.:677-684
Lauber, B.L. et al., "Deposition, Clearance, and Effects in the Lung", Journal of Aerosol Medicine, 4:286
Lauber, B.L. et al., "Preliminary Study of the Efficacy of insulin aerosol delivered by oral inhalation in diabetic patients," 1994, JAMA, 269:2106-2109
Moses, A.C. et al., Insulin administered intranasally as an insulin-bile salt aerosol--Effectiveness and Reproducibility in Normal and Diabetic Subjects, 1983, Diabetes, 32:1040-1047
Newman, S.P. et al., "Deposition of pressurized aerosols in the human respiratory tract", 1981, Thorax, 36:52-55
Newman, S.P. et al., "How should a pressurized γ-adrenergic bronchodilator be inhaled?", 1981, Eur. J. Respir. Dis. 62:3-21
Newman, S.P. et al., "Deposition of pressurized suspension aerosols inhaled through extension devices", 1981, Am. Rev. Respir. Dis. 124:317-320
Newman, S.P., Deposition and Effects of Inhalation Aerosols, 1983
Remington's Pharmaceutical Sciences, A.R. Gennaro, ed., 1985, Mack Publishing Co
Salzman, R.,"Intranasal aerosolized insulin mixed-meal studies and long-term use in type 1 diabetes", 1985, New England Journal of Medicine, 213:1078-1084
Wigley, F.M. et al., "Insulin across respiratory mucosae by aerosol delivery", 1971, Diabetes, 20:552-556
Yoshida, H. et al., "Absorption of insulin delivered to rabbit trachea using aerosol dosage form", 1979, J. Pharmaceutical Sciences 68:670-67
October 27, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
